Orna Therapeutics acquires ReNAgade Therapeutics, appoints new CEO to lead RNA therapeutics innovation
Orna Therapeutics, a pioneer in the field of circular RNA therapeutics, has officially announced its acquisition of ReNAgade Therapeutics, a company renowned for its significant advancements in RNA delivery systems. This strategic move aims to reshape the landscape of RNA medicine by integrating and amplifying the capabilities and technologies of both entities. Following this acquisition, […]